Latest filing published 21 May 2018 for Atara Biotherapeutics, Inc., €1.1M.
Filing timeline
BuySaleInsider track record
Mitchall G. Clark: trading record in brief
Mitchall G. Clark appears in our data through filings on Atara Biotherapeutics, Inc. shares, published by SEC (Form 4). Between 16 January 2015 and 18 May 2018, the trades on record add up to 45 filings.
No open-market purchase appears, only 19 sales worth €5.9M. The rest of the record consists of 8 share grants and 18 option exercises. So far in 2018, the count stands at no purchases and 10 sales.
The newest entry dates from 21 May 2018: an open-market sale of €1.1M, in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mitchall G. Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,860 shares@ US$50.0315.5% of flowCommon StockSEC:0001209191-18-032073:0
- 4,808 shares0Common StockSEC:0001209191-18-030724:0
- 4,347 shares@ US$46.042.4% of flowCommon StockSEC:0001209191-18-030724:1
- 300 shares@ US$46.300.2% of flowCommon StockSEC:0001209191-18-030724:2
- 22,400 shares@ US$40.0710.3% of flowCommon StockSEC:0001209191-18-022904:0
- 28,848 shares@ US$25.158.3% of flowCommon StockSEC:0001209191-18-021991:0
- 32,500 shares@ US$22.728.4% of flowCommon StockSEC:0001209191-18-021991:1
- 11,406 shares@ US$11.001.4% of flowCommon StockSEC:0001209191-18-021991:2
- 22,794 shares@ US$36.439.5% of flowCommon StockSEC:0001209191-18-021991:3
- 31,356 shares@ US$37.1013.2% of flowCommon StockSEC:0001209191-18-021991:4
- 29,980 shares@ US$38.2313.0% of flowCommon StockSEC:0001209191-18-021991:5
- 2,170 shares@ US$39.531.0% of flowCommon StockSEC:0001209191-18-021991:6
- 2,800 shares@ US$40.401.3% of flowCommon StockSEC:0001209191-18-021991:7
- 11,103 shares@ US$41.105.2% of flowCommon StockSEC:0001209191-18-021991:8
- 7,211 shares0Common StockSEC:0001209191-18-011669:0
- 3,604 shares@ US$47.051.9% of flowCommon StockSEC:0001209191-18-011669:1
- 3,704 shares@ US$41.701.8% of flowCommon StockSEC:0001209191-18-009409:0
- 25,000 shares0Common StockSEC:0001209191-18-008509:0
- 4,437 shares@ US$35.801.8% of flowCommon StockSEC:0001209191-18-008509:1
- 7,212 shares0Common StockSEC:0001209191-17-061606:0
- 3,290 shares@ US$14.200.6% of flowCommon StockSEC:0001209191-17-061606:1
- 3,021 shares@ US$14.330.5% of flowCommon StockSEC:0001209191-17-049447:1
- 7,211 shares0Common StockSEC:0001209191-17-049447:0
- 3,873 shares@ US$15.250.8% of flowCommon StockSEC:0001209191-17-033189:1
- 7,212 shares0Common StockSEC:0001209191-17-033189:0
25 of 45 declarations
